Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 3
2007 3
2008 3
2009 16
2010 10
2011 7
2012 15
2013 23
2014 20
2015 15
2016 12
2017 13
2018 10
2019 10
2020 10
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 24575738

153 results
Results by year
Filters applied: . Clear all
Page 1
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).
Bergamo F, Maruzzo M, Basso U, Montesco MC, Zagonel V, Gringeri E, Cillo U. Bergamo F, et al. World J Surg Oncol. 2014 Feb 27;12:46. doi: 10.1186/1477-7819-12-46. World J Surg Oncol. 2014. PMID: 24575738 Free PMC article.
Neoadjuvant or adjuvant sirolimus for malignant metastatic or locally advanced perivascular epithelioid cell tumors: two case reports.
Batereau C, Knösel T, Angele M, Dürr HR, D'Anastasi M, Kampmann E, Ismann B, Bücklein V, Lindner LH. Batereau C, et al. Anticancer Drugs. 2016 Mar;27(3):254-8. doi: 10.1097/CAD.0000000000000324. Anticancer Drugs. 2016. PMID: 26645891
Unresectable hepatic PEComa: a rare malignancy treated with stereotactic body radiation therapy (SBRT) followed by complete resection.
Kirste S, Kayser G, Zipfel A, Grosu AL, Brunner T. Kirste S, et al. Radiat Oncol. 2018 Feb 20;13(1):28. doi: 10.1186/s13014-018-0974-5. Radiat Oncol. 2018. PMID: 29463266 Free PMC article.
PEComa of the colon resistant to sirolimus but responsive to doxorubicin/ifosfamide.
Scheppach W, Reissmann N, Sprinz T, Schippers E, Schoettker B, Mueller JG. Scheppach W, et al. World J Gastroenterol. 2013 Mar 14;19(10):1657-60. doi: 10.3748/wjg.v19.i10.1657. World J Gastroenterol. 2013. PMID: 23539498 Free PMC article.
A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience.
Benson C, Vitfell-Rasmussen J, Maruzzo M, Fisher C, Tunariu N, Mitchell S, Al-Muderis O, Thway K, Larkin J, Judson I. Benson C, et al. Anticancer Res. 2014 Jul;34(7):3663-8. Anticancer Res. 2014. PMID: 24982384
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.
Alaggio R, Cecchetto G, Martignoni G, Bisogno G, Cheng L, Sperlì D, d'Amore ES, Dall'Igna P. Alaggio R, et al. J Pediatr Surg. 2012 Jun;47(6):e31-40. doi: 10.1016/j.jpedsurg.2012.02.023. J Pediatr Surg. 2012. PMID: 22703822 Review.
Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: clinical and molecular correlates.
Dickson MA, Schwartz GK, Antonescu CR, Kwiatkowski DJ, Malinowska IA. Dickson MA, et al. Int J Cancer. 2013 Apr 1;132(7):1711-7. doi: 10.1002/ijc.27800. Epub 2012 Sep 21. Int J Cancer. 2013. PMID: 22927055 Free PMC article.
An unresectable malignant perivascular epithelioid cell tumor resistant to multiple combined chemotherapies: a unique case report.
Peng J, Yu B, Wang J, Hong X, Xu Y, Cai S. Peng J, et al. J Pediatr Hematol Oncol. 2010 May;32(4):e136-8. doi: 10.1097/MPH.0b013e3181b8700b. J Pediatr Hematol Oncol. 2010. PMID: 20051914
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors.
Wagner AJ, Malinowska-Kolodziej I, Morgan JA, Qin W, Fletcher CD, Vena N, Ligon AH, Antonescu CR, Ramaiya NH, Demetri GD, Kwiatkowski DJ, Maki RG. Wagner AJ, et al. J Clin Oncol. 2010 Feb 10;28(5):835-40. doi: 10.1200/JCO.2009.25.2981. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048174 Free PMC article.
Malignant perivascular epithelioid cell tumor of the mesentery: a case report and literature review.
Lai CL, Hsu KF, Yu JC, Chen CJ, Hsieh CB, Chan DC, Li HS, Hsu HM. Lai CL, et al. Onkologie. 2012;35(3):114-7. doi: 10.1159/000336826. Epub 2012 Feb 20. Onkologie. 2012. PMID: 22414975
153 results
Jump to page
Feedback